CClinicalTrials.gg
CompletedNCT05072756Updated Oct 11, 2021

Opinion of Brazilian Gynecologists on Hormone Therapy for Menopause and Prescriptive Habits

An observational study in Menopause, Opinions and Hormone Replacement Therapy, sponsored by Faculdade de Medicina do ABC. Completed at 1 site in Brazil. Per ClinicalTrials.gov, last updated 2021-10-11.

Sponsored by Faculdade de Medicina do ABC · Observational

Study type
Observational
Model
Case-only
Time perspective
Cross-sectional
Enrollment
1,339
Sex
All
01

Study summary

To evaluate Brazilian gynecologists, through structured online questionnaires, with questions directed to their opinions and prescriptive habits about menopause hormone therapy. Research participants will complete the questionnaires in digital format online.

Read the detailed description

There are few Brazilian population studies on the opinion of Brazilian gynecologists about the hormonal therapy of menopause in climacteric women, their prescriptive habits and their views on the availability of treatments offered, demanding better evaluation and justifying efforts to analyze the perception of professionals in this area in our country.

Methods: To assess gynecologists across the country, through structured online questionnaires, with questions aimed at knowing their opinions and prescriptive habits about menopause hormone therapy. Research participants will complete the questionnaires in digital format online. Doctors will be invited to participate by e-mail messages and by social media.

02

Conditions studied

  • Menopause
  • Opinions
  • Hormone Replacement Therapy
03

In context

Lead sponsor

Faculdade de Medicina do ABC is the lead sponsor of 26 studies on the registry; none are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

Active Brazilian licensed gynecologist doctors who see patients

Inclusion criteria

  • Brazilian licensed gynecologist doctors

Exclusion criteria

Exclusion Criteria:

  • Retired doctors
  • Health professionals other than medicine doctor
  • Medical specialties other than Gynecology
  • Medical employees of the pharmaceutical industry
05

Study design

Observational model
Case-only
Time perspective
Cross-sectional
Enrollment
1,339 participants (actual)
Patient registry
No

Groups and cohorts

  • Gynecologists

    Brazilian gynecologists who agreed to participate and answered the questionnaire

    Other: Applying a questionnaire

Interventions

  • OtherApplying a questionnaire

    The participants have to answer a questionnaire addressing their opinion on menopausal hormone replacement therapy

06

What researchers measure

Primary outcomes

  1. Prescription preference

    Answer to the questionnaire addressing gynecologists' prescription habit for menopausal women

    Time frame: At Day 1

Secondary outcomes

  1. Knowledge of window of opportunity for hormone replacement therapy

    This is to see which proportion of gynecologists know the principle of window of opportunity for menopausal hormone replacement therapy

    Time frame: At Day 1

  2. Knowledge of indications and contraindications of hormone replacement therapy

    This is to see which proportion of gynecologists know the indications and contraindicationsv of menopausal hormone replacement therapy

    Time frame: At Day 1

07

Study locations

1 site
  • Centro de Atenção Integral à Saúde da Mulher
    São Bernardo do Campo, SP 09760-280, Brazil
08

References and documents

Publications

  • Taylor HS, Kagan R, Altomare CJ, Cort S, Bushmakin AG, Abraham L. Knowledge of clinical trials regarding hormone therapy and likelihood of prescribing hormone therapy. Menopause. 2017 Jan;24(1):27-34. doi: 10.1097/GME.0000000000000711. PubMed 27575548 ↗
  • Buhling KJ, von Studnitz FS, Jantke A, Eulenburg C, Mueck AO. Use of hormone therapy by female gynecologists and female partners of male gynecologists in Germany 8 years after the Women's Health Initiative study: results of a survey. Menopause. 2012 Oct;19(10):1088-91. doi: 10.1097/gme.0b013e318250bfda. PubMed 22692331 ↗
  • Yeganeh L, Boyle J, Teede H, Vincent A. Knowledge and attitudes of health professionals regarding menopausal hormone therapies. Climacteric. 2017 Aug;20(4):348-355. doi: 10.1080/13697137.2017.1304906. Epub 2017 Apr 5. PubMed 28379046 ↗

Individual participant data

Plan to share: No — This is not an interventional study, so, the researches understand that there is no reason to share individual participant data.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 11, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05072756
Lead sponsor
Faculdade de Medicina do ABC
Responsible party
Luciano de Melo Pompei' (Auxiliary Professor at Gynecology Department, Faculdade de Medicina do ABC) — Principal investigator
First posted
Oct 11, 2021
Start date
Apr 28, 2021
Primary completion
Sep 4, 2021
Completion
Sep 4, 2021
Last update
Oct 11, 2021

Study contacts

Luciano M Pompei
principal investigator · Faculdade de Medicina do ABC

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion